Natasha Gloeck
Dados Biográficos
| ID | 9064192 |
|---|---|
| NOME | Natasha Gloeck |
| PRENOMES | Natasha |
| SOBRENOME | Gloeck |
| ASSINATURA | GLOECK N |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2023 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2023 |
| ÍNDICE H | 0 |
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…
Sem obras proeminentes nesta página.
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with Covid-19 in children aged 5 to 11 years
A rapid systematic review, based on Cochrane rapid review methodology was conducted to assess the effectiveness of two 10μg doses of BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years. We searched the Cochrane Library COVID-19 study register, the COVID-NMA living review database and the McMaster University Living Evidence Synthesis for pre-appraised trials and observational studies up to…